GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmunoPrecise Antibodies Ltd (STU:TQB) » Definitions » DeferredTaxAndRevenue

ImmunoPrecise Antibodies (STU:TQB) DeferredTaxAndRevenue : €1.78 Mil (As of Jan. 2025)


View and export this data going back to 2022. Start your Free Trial

What is ImmunoPrecise Antibodies DeferredTaxAndRevenue?

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

ImmunoPrecise Antibodies's current deferred tax and revenue for the quarter that ended in Jan. 2025 was €1.78 Mil.

ImmunoPrecise Antibodies DeferredTaxAndRevenue Historical Data

The historical data trend for ImmunoPrecise Antibodies's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ImmunoPrecise Antibodies DeferredTaxAndRevenue Chart

ImmunoPrecise Antibodies Annual Data
Trend Dec14 Dec15 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24
DeferredTaxAndRevenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.16 1.08 1.30 0.96 1.12

ImmunoPrecise Antibodies Quarterly Data
Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.58 1.12 1.07 1.35 1.78

ImmunoPrecise Antibodies DeferredTaxAndRevenue Related Terms

Thank you for viewing the detailed overview of ImmunoPrecise Antibodies's DeferredTaxAndRevenue provided by GuruFocus.com. Please click on the following links to see related term pages.


ImmunoPrecise Antibodies Business Description

Traded in Other Exchanges
Address
Industrious 823 Congress Avenue, Suite 300, Austin, TX, USA, 78701
ImmunoPrecise Antibodies Ltd is a techbio company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges. IPA has several subsidiaries in North America and Europe.

ImmunoPrecise Antibodies Headlines

No Headlines